{"id":"https://openalex.org/W2060201261","doi":"https://doi.org/10.1158/1538-7445.am2011-5154","title":"Abstract 5154: Serotonin signaling as a novel target of tumor angiogenesis","display_name":"Abstract 5154: Serotonin signaling as a novel target of tumor angiogenesis","publication_year":2011,"publication_date":"2011-04-01","ids":{"openalex":"https://openalex.org/W2060201261","doi":"https://doi.org/10.1158/1538-7445.am2011-5154","mag":"2060201261"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2011-5154","doi":"https://doi.org/10.1158/1538-7445.am2011-5154","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-5154","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Ali Zamani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ali Zamani","raw_affiliation_strings":["1UAB, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1UAB, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108512263","display_name":"Ling Zhai","orcid":"https://orcid.org/0009-0001-3056-5171","observed_orcids":["https://orcid.org/0009-0001-3056-5171"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ling Zhai","raw_affiliation_strings":["2SRI, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2SRI, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052998843","display_name":"Anshu Mittal Roy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anshu M. Roy","raw_affiliation_strings":["2SRI, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2SRI, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000514275","display_name":"Rongbao Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rongbao Li","raw_affiliation_strings":["2SRI, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2SRI, Birmingham, AL","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002938075","display_name":"Zhican Qu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhican Qu","raw_affiliation_strings":["2SRI, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2SRI, Birmingham, AL","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021533593","display_name":"Yulia Y. Maxuitenko","orcid":"https://orcid.org/0000-0001-5518-4941","observed_orcids":["https://orcid.org/0000-0001-5518-4941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yulia Y. Maxuitenko","raw_affiliation_strings":["2SRI, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2SRI, Birmingham, AL","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"71","issue":"8_Supplement","first_page":"5154","last_page":"5154"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/serotonin-signaling","display_name":"serotonin signaling","score":0.8370000123977661},{"id":"https://openalex.org/keywords/tumor-angiogenesis","display_name":"tumor angiogenesis","score":0.9869999885559082},{"id":"https://openalex.org/keywords/platelets","display_name":"platelets","score":0.6949999928474426},{"id":"https://openalex.org/keywords/serotonin-receptors","display_name":"serotonin receptors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/anti-angiogenic-therapy","display_name":"anti-angiogenic therapy","score":0.75},{"id":"https://openalex.org/keywords/vegfr-tyrosine-kinase-inhibitors","display_name":"VEGFR inhibitors","score":0.6660000085830688},{"id":"https://openalex.org/keywords/endothelial-cell-proliferation","display_name":"endothelial cell proliferation","score":0.7020000219345093},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.5960000157356262},{"id":"https://openalex.org/keywords/g-protein-coupled-receptors","display_name":"G protein-coupled receptors","score":0.800000011920929}],"concepts":[{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.8716062307357788},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6085942983627319},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5475011467933655},{"id":"https://openalex.org/C2778608917","wikidata":"https://www.wikidata.org/wiki/Q6787805","display_name":"Matrigel","level":3,"score":0.5246025323867798},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.48947441577911377},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.43730926513671875},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4221184253692627},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4126977324485779},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.40878328680992126},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.3905634880065918},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.37600335478782654},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3741314709186554},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.312127947807312},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.06276017427444458}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2011-5154","doi":"https://doi.org/10.1158/1538-7445.am2011-5154","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2011-5154","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1968532464","https://openalex.org/W2069600451","https://openalex.org/W3214545815","https://openalex.org/W77745191","https://openalex.org/W2087324461","https://openalex.org/W2107197642","https://openalex.org/W2270608545","https://openalex.org/W2547561446","https://openalex.org/W1975224367","https://openalex.org/W2134990962"],"abstract_inverted_index":{"Abstract":[0],"Angiogenesis":[1,28],"is":[2,7,128,149,154],"a":[3,58,265,288,307],"well-controlled":[4],"process":[5],"that":[6,12,107,143,166,188,302],"regulated":[8],"by":[9,15,55,214],"multiple":[10,179],"factors":[11,104],"are":[13,30,50,53,72,108],"secreted":[14],"the":[16,25,48,131,200,206,232,270,326,331],"cancer":[17,93],"cells":[18,23,168],"as":[19,21],"well":[20],"other":[22,101],"within":[24],"tumor":[26,61,114,255,311],"microenvironment.":[27],"inhibitors":[29,106],"showing":[31],"therapeutic":[32,315],"efficacy":[33,76],"in":[34,42,92,147,151,231,250,273,284,313],"an":[35,262],"increasing":[36],"number":[37],"of":[38,60,85,134,145,181,194,202,229,245,298,310,325,330],"human":[39],"cancers.":[40],"However,":[41],"both":[43],"preclinical":[44],"and":[45,52,57,63,77,87,105,112,153,172,198,242],"clinical":[46],"settings,":[47],"benefits":[49],"transitory":[51],"followed":[54],"resistance":[56,79],"restoration":[59],"growth":[62,103,125,175],"progression.":[64],"Therefore,":[65],"novel":[66,308],"anti-angiogenic":[67],"strategies":[68],"with":[69,286],"complementary":[70],"mechanisms":[71],"needed":[73],"to":[74,80,191],"maximize":[75],"minimize":[78],"current":[81],"angiogenesis":[82,239,256,312],"inhibitors.":[83],"Activation":[84],"platelets":[86,98,152],"blood":[88,148,157,277],"coagulation":[89],"frequently":[90],"occurs":[91],"patients.":[94],"Apart":[95],"from":[96],"VEGF,":[97],"contain":[99],"several":[100],"angiogenic":[102,216,226],"released":[109,155],"upon":[110],"activation":[111],"promote":[113],"neoangiogenesis.":[115],"Although":[116],"considerable":[117],"attention":[118],"has":[119,174,211],"been":[120,212],"focused":[121],"on":[122,178],"platelet":[123,136],"peptide":[124],"factors,":[126,217],"little":[127],"known":[129],"about":[130],"mitogenic":[132],"effects":[133],"nonpeptide":[135],"products":[137],"such":[138],"s":[139],"serotonin":[140],"(5-HT),":[141],"considering":[142],"99%":[144],"5-HT":[146,170,173,189,230,248,267,303],"found":[150],"at":[156],"clotting":[158],"sites.":[159],"In":[160,220],"previous":[161],"studies,":[162,223],"we":[163,224],"have":[164,185],"shown":[165],"endothelial":[167,182],"express":[169],"receptors":[171,197,249],"stimulatory":[176],"effcts":[177],"types":[180],"cells.":[183],"We":[184],"also":[186],"demonstrated":[187,269],"binds":[190],"inhibitory":[192],"type":[193],"G-protein":[195],"coupled":[196],"stimulates":[199],"phosphorylation":[201],"PYK2/PI3K/AKT/mTOR":[203],"signaling":[204,208,304],"pathway,":[205,209],"same":[207],"which":[210],"activated":[213],"most":[215,260],"including":[218],"VEGF.":[219],"our":[221],"recent":[222],"explored":[225],"promoting":[227],"activity":[228],"mouse":[233],"matrigel":[234],"plug":[235],"assay":[236,252],"(in":[237],"vivo":[238,254],"model":[240,257],"system)":[241],"antiangiogenic":[243,291],"potential":[244],"antagonists":[246],"against":[247,264,293],"xenograft-CAM":[251],"(ex":[253],"system).":[258],"The":[259,296],"importantly,":[261],"antagonist":[263],"specific":[266],"receptor":[268],"synergistic":[271],"effect":[272],"blocking":[274],"tumor-induced":[275],"new":[276],"vessel":[278],"formation":[279],"when":[280],"it":[281],"was":[282],"applied":[283],"combination":[285],"Sutent,":[287],"FDA":[289],"approved":[290],"drug":[292],"VEGF":[294],"receptor.":[295],"results":[297],"this":[299],"study":[300],"suggest":[301],"pathway":[305],"constitute":[306],"target":[309],"anticancer":[314],"development.":[316],"Citation":[317],"Format:":[318],"{Authors}.":[319],"{Abstract":[320],"title}":[321],"[abstract].":[322],"In:":[323],"Proceedings":[324],"102nd":[327],"Annual":[328],"Meeting":[329],"American":[332],"Association":[333],"for":[334],"Cancer":[335,345],"Research;":[336],"2011":[337],"Apr":[338],"2-6;":[339],"Orlando,":[340],"FL.":[341],"Philadelphia":[342],"(PA):":[343],"AACR;":[344],"Res":[346],"2011;71(8":[347],"Suppl):Abstract":[348],"nr":[349],"5154.":[350],"doi:10.1158/1538-7445.AM2011-5154":[351]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2013,"cited_by_count":2}],"updated_date":"2026-10-29T09:56:32.521200","created_date":"2016-06-24T00:00:00"}